Understanding CYFRA 21-1 and Its Related Markers in Lung Cancer

Learn about CYFRA 21-1, a lung cancer marker, and how it relates to other markers in diagnosing and monitoring lung cancer.

Aug 18, 2026 3 min read

CYFRA 21-1 is a blood test that measures a specific protein fragment associated with lung cancer, particularly non-small cell lung cancer (NSCLC). It is crucial for diagnosing and monitoring the progression or recurrence of cancer. Understanding CYFRA 21-1 and its related markers can help patients and doctors make informed decisions about lung cancer treatment and management.

What is CYFRA 21-1?

CYFRA 21-1 is a fragment of cytokeratin 19, a protein found in the epithelial cells that line the airways and other parts of the body. When these cells become cancerous, they release more of this protein into the bloodstream. Measuring the level of CYFRA 21-1 can help indicate the presence and extent of lung cancer, especially non-small cell lung cancer (NSCLC).

Why CYFRA 21-1 Matters

CYFRA 21-1 is used primarily in the context of lung cancer, as it helps in diagnosing and monitoring the disease. High levels of CYFRA 21-1 in the blood may suggest the presence of lung cancer or its progression. It can also be used to monitor how well a patient is responding to treatment. However, elevated levels of CYFRA 21-1 can also occur in other conditions, such as certain benign lung diseases, so it is usually considered alongside other tests and clinical findings.

When assessing lung cancer, CYFRA 21-1 is often considered alongside other tumor markers like CEA (Carcinoembryonic Antigen) and NSE (Neuron Specific Enolase). CEA is another protein that can be elevated in lung cancer and other cancers, providing additional information about the presence and progression of the disease. NSE is more specific to neuroendocrine tumors of the lung. Together, these markers can offer a more comprehensive picture of the cancer’s characteristics and help in tailoring the treatment plan.

Reading Your CYFRA 21-1 Results

Interpreting CYFRA 21-1 results involves comparing your levels to a standard reference range, which can vary slightly depending on the laboratory. Generally, lower levels are considered normal, while higher levels may indicate the presence of lung cancer. It's important to discuss your results with your doctor, as they will consider your medical history and any other test results to provide a complete interpretation.

Practical Next Steps

If your CYFRA 21-1 levels are elevated, your doctor may recommend further testing, such as imaging studies (like a CT scan) or a biopsy, to confirm the presence of lung cancer. If you are undergoing treatment, regular monitoring of CYFRA 21-1 levels can help assess how well the treatment is working and whether any adjustments are needed.

Frequently Asked Questions

What does a high CYFRA 21-1 level mean?

A high level of CYFRA 21-1 may indicate the presence of lung cancer, particularly non-small cell lung cancer. However, it can also be elevated in other conditions, so further testing is usually needed.

Can CYFRA 21-1 be used to screen for lung cancer?

CYFRA 21-1 is not typically used as a screening tool for lung cancer in the general population. It is more commonly used to monitor known cases of lung cancer.

Is it possible to have lung cancer with normal CYFRA 21-1 levels?

Yes, it is possible to have lung cancer with normal CYFRA 21-1 levels, as not all lung cancers produce this marker. Other diagnostic tools and tests are often necessary.

How often should CYFRA 21-1 levels be checked?

The frequency of testing depends on your specific situation and should be determined by your healthcare provider, especially if you are undergoing treatment for lung cancer.

When to See a Doctor

You should consult a doctor if you have symptoms suggestive of lung cancer, such as a persistent cough, unexplained weight loss, or difficulty breathing. If you have been diagnosed with lung cancer, regular follow-up appointments with your healthcare provider are essential to monitor your condition and adjust treatment as needed.

Decisions about your health should always be made in consultation with your healthcare provider, who can provide guidance based on your individual situation.

Read this in another language

Doctor reviews: 0 - pending

This explainer is queued for our doctor panel and hasn't been individually reviewed yet. It's general information, drawn from standard references - always confirm decisions with your own clinician.

Have your own lab results? Upload your report and get a clear, private AI explanation in minutes — free, in English, Russian or Hebrew.
Analyze my results
Want a verified MD opinion on your own report? From $25, 72-hour SLA. Licensed doctors review your file directly.
Browse doctors